CSS
COGT icon

Cubist Systematic Strategies’s Cogent Biosciences COGT Stock Holding History

Cubist Systematic Strategies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,230
Closed -$131K – 3071
2025
Q2 		$131K Sell
18,230
-104,600
-85% -$580K ﹤0.01% 2673
2025
Q1 		$736K Hold
122,830
– – ﹤0.01% 1974
2024
Q4 		$958K Sell
122,830
-7,268
-6% -$72.4K 0.01% 1824
2024
Q3 		$1.41M Sell
130,098
-4,562
-3% -$44.4K 0.01% 1611
2024
Q2 		$1.14M Buy
134,660
+34,655
+35% +$263K 0.01% 1666
2024
Q1 		$672K Buy
100,005
+66,031
+194% +$408K ﹤0.01% 2432
2023
Q4 		$200K Buy
+33,974
New +$260K ﹤0.01% 3006
2023
Q2 		– Sell
-27,582
Closed -$298K – 3616
2023
Q1 		$298K Sell
27,582
-20,459
-43% -$262K ﹤0.01% 3001
2022
Q4 		$555K Sell
48,041
-54,326
-53% -$673K ﹤0.01% 2949
2022
Q3 		$1.53M Buy
102,367
+26,815
+35% +$368K 0.01% 2255
2022
Q2 		$681K Buy
75,552
+75,462
+83,847% +$515K ﹤0.01% 2799
2022
Q1 		$1K Buy
+90
New +$627 ﹤0.01% 3520
2018
Q3 		– Sell
-1,568
Closed -$90K – 1909
2018
Q2 		$90K Buy
+1,568
New +$75.4K ﹤0.01% 1565

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Cubist Systematic Strategies's COGT Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Cogent Biosciences (COGT) in Q3 2025, closing a stake of 18,230 shares — an estimated $131K sold.

Cubist Systematic Strategies first reported a position in COGT in Q2 2018 and held it in 13 quarters. The position peaked at $1.53M in Q3 2022. 195 funds tracked by Wall St. Rank hold COGT as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Cogent Biosciences position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 18,230 Cogent Biosciences shares in Q3 2025, an estimated $131K.
  • Cubist Systematic Strategies first reported a position in Cogent Biosciences in Q2 2018 and held it in 13 quarters.
  • Cubist Systematic Strategies's Cogent Biosciences position peaked at $1.53M in Q3 2022.
  • 195 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.